Pulmonary function tests (PFTs) are integral to the diagnosis and management of respiratory diseases. However, their interpretation can be complex, requiring a comprehensive understanding of respiratory physiology and pathology. This guide aims to simplify the interpretation process for healthcare professionals.
Spirometry is the cornerstone of PFTs, providing information about airflow and lung volumes. Key parameters include Forced Vital Capacity (FVC), Forced Expiratory Volume in one second (FEV1), and their ratio (FEV1/FVC). Abnormal results can indicate obstructive or restrictive lung diseases, with the pattern of changes providing diagnostic clues.
Diffusing capacity of the lungs for carbon monoxide (DLCO) assesses the efficiency of gas exchange across the alveolar-capillary membrane. Reduced DLCO may indicate conditions such as interstitial lung disease, pulmonary hypertension, or emphysema.
Total Lung Capacity (TLC), Functional Residual Capacity (FRC), and Residual Volume (RV) are measured using body plethysmography or gas dilution techniques. Elevated volumes suggest air trapping as seen in obstructive diseases, while reduced volumes indicate restrictive pathology.
Cardiopulmonary exercise testing (CPET) evaluates the integrative exercise responses involving the pulmonary, cardiovascular, hematopoietic, neuropsychological, and skeletal muscle systems. Abnormalities in oxygen uptake, ventilation, or heart rate responses can provide insights into the severity and nature of the disease.
Interpreting PFTs is a multifaceted process that requires a thorough understanding of the tests and their implications. Proficiency in PFT interpretation can greatly enhance clinical decision-making and patient management in respiratory medicine. As healthcare professionals, we must continually strive to enhance our skills in this critical area of practice.
1.
A Lot Can Be Said About You by Including Yourself in Photos.
2.
A new blood test greatly increases the ability to detect cancer.
3.
Novel biomarker has potential for predicting and treating skin cancer metastasis
4.
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC
5.
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer
1.
Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy
2.
Preventing Treatment-Related Secondary Malignancies: Evidence-Based Strategies for Clinical Practice
3.
Contemporary Frameworks in Oncology Across Clinical Settings
4.
What is Mullerian and How Does it Affect Your Health
5.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding Common Causes of Abnormal Blood Counts
2.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Understanding Cancer: Early Detection and Treatment
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation